MyoSwiss is an ETH spin-off medtech company focused on improving quality of life for people with mobility impairments by enabling physical activity. Its flagship product, the Myosuit, is a wearable muscle (exomuscle) that combines robotics and functional textiles to support walking, stair negotiation, standing up and sitting down. The company positions the Myosuit as state‑of‑the‑art technology that is accessible to the public. Three years after its foundation, MyoSwiss has secured additional capital to accelerate growth and market entry. The newly raised funds will support business activities aimed at faster commercialization. CEO Jaime Duarte emphasized that the investment and partnerships will allow the company to grow further and speed up its business development.

Total raised

$2M

Funding rounds

1

Latest round

Equity

Latest activity

Jul 2020